RAPT Therapeutics Inc.

NASDAQ: RAPT · Real-Time Price · USD
11.79
0.54 (4.80%)
At close: Aug 15, 2025, 3:59 PM
11.65
-1.18%
After-hours: Aug 15, 2025, 06:13 PM EDT

RAPT Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-3.97 -65.25 -62.95 -118
PEG Ratio
-0.86 -3.1 -52.25 -8.61
PS Ratio
n/a n/a 3.38K 2.11K
PB Ratio
2.71 51.84 21.02 43.18
P/FCF Ratio
-6.18 -77.63 -71.97 -130.27
P/OCF Ratio
-6.19 -78.53 -72.83 -131.88
OCF/S Ratio
n/a n/a -46.35 -16
Debt / Equity Ratio
0.02 0.05 0.04 n/a
Quick Ratio
4.87 7.41 17.77 20.11
Current Ratio
4.87 7.41 17.77 20.11
Asset Turnover
n/a n/a 0.01 0.02
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-0.68 -0.79 -0.33 -0.37
Return on Assets
-0.54 -0.67 -0.31 -0.34
Return on Invested Capital
-0.7 -0.83 -0.33 -0.36
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a -0.84 0.74
Net Profit Margin
n/a n/a -53.62 -17.89
Pretax Profit Margin
n/a n/a -54.9 -18.15
Operating Profit Margin
n/a n/a -56.19 -18.15
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a -55.5 -17.89